REQUEST A DEMO
Total
USD $0.00
Search more companies

Sanofi - Aventis del Ecuador S.A. (Ecuador)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Sanofi - Aventis del Ecuador S.A. Profile Updated: April 12, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Sanofi, is a player in the Turkish pharmaceutical sector, focusing on R&D, production investments, and exports. The company aims to become a global drug R&D and production center, contributing to a healthy life by increasing the added value produced by international direct investments and domestic production in medicine. Sanofi Turkey produces 88% of its portfolio volume and 48% of its portfolio value, as well as 15% of the total pharmaceutical production at its Lüleburgaz manufacturing site. The company is committed to reducing and managing waste with potential environmental and health impacts through efficient use of resources.

Headquarters
Av. Simon Bolivar, Torre 2 Bldg. , Floor 5
Quito; Pichincha;

Contact Details: Purchase the Sanofi - Aventis del Ecuador S.A. report to view the information.

Website: http://www.sanofi.com

Basic Information
Total Employees:
Purchase the Sanofi - Aventis del Ecuador S.A. report to view the information.
Outstanding Shares:
Purchase the Sanofi - Aventis del Ecuador S.A. report to view the information.
Registered Capital:
Purchase the Sanofi - Aventis del Ecuador S.A. report to view the information.
Incorporation Date:
June 06, 1979
Key Executives
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Financial Director
Ownership Details
Purchase this report to view the information.
100%
Purchase this report to view the information.
Subsidiaries
Laboratorios Genericos Farmaceuticos Ecuatorianos S.A. Genfar Ecuador
100%
Opella Healthcare Ecuador S.A.S.
100%
Company Performance
Financial values in the chart are available after Sanofi - Aventis del Ecuador S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
98.09%
Total assets
-26.48%
Total equity
-1.92%
Debt to Equity Ratio
3.21%
Quick Ratio
2.51%
Cash Ratio
0.55%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?